New Breast Cancer Research Has Been Reported by Researchers at Peking Union Medical College (Quantifying spatial CXCL9 distribution with image analysis predicts improved prognosis of triple-negative breast cancer).

A recent study conducted by researchers at Peking Union Medical College in Beijing, China, explored the relationship between the expression of the chemokine CXCL9 and the prognosis of triple-negative breast cancer (TNBC). The study found that high levels of CXCL9 mRNA expression were associated with smaller tumors, earlier stages of cancer, and improved overall survival in TNBC patients. Additionally, low levels of CXCL9 protein expression were linked to increased lymph node metastasis. The researchers concluded that CXCL9 expression may serve as an independent prognostic factor for TNBC patients. [Extracted from the article]

Copyright of Women's Health Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)